News
Concerns voiced as Palantir wins £330m NHS data contract
NHS England has awarded US IT group Palantir the contract to create a …
19781 items found
Patients
Pharmacy First: Why technology is necessary for safeguarding pharmacies
The challenges facing UK healthcare are abundantly clear. With …
R&D
Talking techbio with NVIDIA: Accelerated computing, NLP, and GenAI in drug discovery
As Genentech and NVIDIA enter into a multi-year strategic AI research …
Market Access
AMR could kill 10M in 2050, but there’s little profit in stopping it
Last month, the Novo Nordisk Foundation welcomed a group of …
R&D
A forgotten opioid epidemic, but a mounting problem
Deaths from opioid-related overdoses continue to grow in the US, but …
News
Genentech, NVIDIA partner on ‘lab-in-a-loop’ AI platform
NVIDIA’s push into the life sciences sector has been rewarded by a …
News
MorphoSys shrugs off mixed results for myelofibrosis drug
MorphoSys has said it will press ahead with regulatory filings for …
News
MSD reaches $610m deal to buy lysosome biotech Caraway
MSD has agreed to pay up to $610 million to acquire Caraway …
Digital
Digital measures for value-based healthcare: Current perspectives
In the ever-evolving landscape of healthcare, the concept of …
News
GSK says new inhaler will help slash its carbon footprint
GSK has developed a new propellant technology for inhaler devices …
Patients
The rare disease treatment revolution: Pioneering patient-centric transformation in pharmaceutical customer engagement
With over 30 million individuals in the United States alone affected …
R&D
Immunometabolism: Providing a new era of targeted medicine
In a new episode of the pharmaphorum podcast, web editor Nicole …
R&D
Partner Content
Europe’s Largest Industry-Led & Dedicated Gathering for mRNA...
The 4th mRNA-Based Therapeutics Summit Europe returns to Frankfurt, Germany as the industry’s premier forum dedicated to showcasing the hottest disease targets,
Sales & Marketing
Enabling site success: Key insights to reducing burden and i...
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.
Sales & Marketing
Deep Dive: Commercialisation 2024
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
Digital
A journey from personal to public: Digital health passports ...
A digital health passport is an app, or online certification, that displays a traveller’s health or vaccination record. It can save lives, on both private and public levels.
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
R&D
Partner Content
9th Microbiome Movement Summit Europe
Translating Microbiome R&D into Improved Healthcare Outcomes & Commercial Potential
R&D
Partner Content
Proteomic Based Drug Discovery Summit 2025
Determine Optimum Application of Proteomics to Accelerate Screening of Novel Targets, Unravel the Mode of Action, & Identify Biomarkers to Progress Small Molecule Drug Discovery & T
